CUV 0.67% $14.72 clinuvel pharmaceuticals limited

Ann: Syd Capital Markets Briefing Presentation, page-34

  1. 16,263 Posts.
    lightbulb Created with Sketch. 4311
    They have finally released the video of the presentation. Really impressive presentation in my view, covering their unique strategy and explaining quite clearly why this approach will likely deliver substantial returns in the longer run. Not surprised the buying volume is beginning to grow, obviously the buy back helps but it is quite clear that the price is simply too low considering the quality of this company and its fundamentals.

 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.